Cristina Maccalli

Staff Scientist at the Immunology and Therapy Section

Sidra Medical and Research Center, Qatar

Cristina Maccalli is a Staff Scientist at the Immunology and Therapy Section, Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. Cristina obtained in 1990 a Master’s Degree in Biological Sciences and then, in 1996, a Ph.D. in Applied Genetics at the University of Milan, Italy. Her research interest lies in the area of tumor immunology and immunotherapy, with main focus on the immunomonitoring and characterization of immune responses in cancer patients. She has carried out her research programs at the National Cancer Institute in Milan, Italy and, then, at the Surgery Branch, National Cancer Institute, NIH, Bethesda, MD, USA. Were she was dedicated to the deep characterization of cancer patients’ immune responses and the identification of tumor antigens recognized by T cells in patients with melanoma and colorectal cancer. In 2007 Cristina joined the Unit of Immuno-biotherapy of Melanoma and Solid Tumors at the San Raffaele Foundation Scientific Institute, Milan, Italy and her interests were focus on the development of to novel studies on the immunological characterization of cancer stem cells from glioblastoma, and colorectal cancer patients and to perform monitoring of immune responses in cancer patients undergoing immunotherapy. She collaborated to the development of immunotherapy Phase I/II clinical studies for melanoma patients. In 2013 she contributed to set up in the context of the Italian Network for Biotherapy of Tumors-(NIBIT) a novel laboratory dedicated to the identification and the design of standardized and validated immunomonitoring assays for cancer patients. Recently, Cristina joined the Translational Medicine Department at Sidra Medical and Research Center, Doha, Qatar, where she is involved in development of innovative studies in the context of biomarker discovery and immunotherapy. Cristina is author/co-author of about 50 original peer-reviewed publications and chapter books. She is Associate Editor of The Journal of Translational Medicine and reviewer of a international scientific journals, e.g. Cancer Res., Clin. Cancer Res., J. Immunol. JTM, PlosOne. She acted as lecturer for elective courses on Melanoma at the University “Vita e Salute”, San Raffaele, Milan, Italy and for the Joint International PhD Course Molecular Oncology, Experimental Immunology and New Drugs Development: University Magna Grecia, Karolinska Institute, University of Freiburg, University of Turin.Moreover, she was lecturer for ImmunOncology educational courses in the context of NIBIT. She is member of the Society of Immunotherapy of Cancer (SITC) and of NIBIT. In the context of SITC she has served as member of workshops and working groups on immunotherapy biomarkers.